InsiderTrades

Form 4 for TMO Thermo Fisher Scientific

Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-09 · accession 0001127602-21-023457 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-10 2021-08-09 TMO Holmes Joseph R. VP, CAO M - OptEx $198.21 +759 1,372 +124% +$150.4K
DM 2021-08-10 2021-08-09 TMO Holmes Joseph R. VP, CAO S - Sale+OE $542.76 -759 897 -46% -$412.0K
DM 2021-08-10 2021-08-09 TMO Holmes Joseph R. VP, CAO M - OptEx $0.00 -759 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-09 M A 284 $177.35 1,181 D — — (F1) Includes 55 shares acquired under the Issuer's employees' stock purchase plan on May 14, 2021.
2 Common Common Stock 2021-08-09 M A 475 $210.68 1,372 D — —
3 Common Common Stock 2021-08-09 S D 475 $542.77 897 D — —
4 Common Common Stock 2021-08-09 S D 284 $542.73 897 D — —
5 Derivative Stock Option (Right to Buy) 2021-08-09 M D 475 $0.00 475 D $210.68 · — to 2025-02-27 475 Common Stock (F3) The option vests in four equal annual installments. One-quarter of the shares vested on February 27, 2019, 2020 and 2021, and the remaining one-quarter will vest on February 27, 2022.
6 Derivative Stock Option (Right to Buy) 2021-08-09 M D 284 $0.00 0 D $177.35 · — to 2024-08-07 284 Common Stock (F2) The option vested in four equal installments on August 7, 2018, 2019, 2020, and 2021.